Sunrise provides an FDA‑cleared, ISO‑13485‑certified at‑home sleep apnea testing system that combines a 3‑gram forehead sensor with a smartphone app to record and analyze respiratory and oxygen data overnight. The platform automatically generates a clinician‑ready report with AHI, desaturation and sleep‑stage metrics and securely delivers it to physicians via a HIPAA‑compliant portal, eliminating the need for in‑lab polysomnography.
Funding
$29.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diagnosing obstructive sleep apnea traditionally requires overnight polysomnography in a sleep lab, which involves costly equipment, scheduling delays, and patient inconvenience. Limited access to such facilities leads to underdiagnosis and delayed treatment for many individuals with suspected sleep‑disordered breathing.
Solution
Sunrise delivers a certified, FDA‑cleared medical device that enables at‑home sleep apnea testing with clinical‑grade accuracy. A lightweight 3‑gram sensor attaches to the patient’s forehead and streams physiological data to a dedicated smartphone application throughout the night. The app automatically processes the signals, generates a comprehensive report, and securely transmits the results to the patient’s physician for immediate review. By eliminating the need for in‑lab equipment and technician oversight, Sunrise reduces logistical complexity, shortens the diagnostic pathway, and supports timely, personalized treatment decisions. The solution also includes a follow‑up service that connects patients with sleep‑medicine specialists for customized care plans.
Target Audience
The primary customers are adults with suspected sleep apnea who seek a convenient at‑home diagnostic option, and sleep physicians or clinics that require reliable, remotely generated sleep study reports. Sunrise also serves employers, insurers, and medical distributors looking to offer scalable sleep‑health solutions to their members or clients.
Features
- FDA De Novo cleared, ISO 13485‑certified sensor delivering hospital‑level accuracy for apnea‑hypopnea index (AHI) measurement
- 3‑gram ultra‑lightweight wearable with built‑in accelerometer and pulse oximetry, powered for a full night of recording
- Cross‑platform iOS and Android app that handles data acquisition, real‑time quality monitoring, and automated signal processing using validated algorithms
- End‑to‑end encryption and HIPAA‑aligned data handling; results are stored in a cloud‑based repository accessible via a secure physician portal
- Automated, clinician‑ready report containing AHI, oxygen desaturation metrics, and sleep‑stage summary, exportable in PDF or HL7 format
- Home delivery kit with quick‑start guide, enabling self‑installation without technical support
- Clinical validation backed by 10 years of research, >15 peer‑reviewed publications, and >95 % patient satisfaction scores